Redwood City, CA, United States of America

Adam James Schrier

This inventor holds 23 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Antiviral Compounds. Top assignees: Gilead Sciences, Inc., Selcia Limited, Cypralis Limited. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adam James Schrier. Retrieved from https://idiyas.com/inventor/adam-james-schrier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 8)

% Patents Active = 69.6

CIPO Patents = 3 (Patent Applications = 3)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 15.7

ph-index = 6

Forward Citations = 66(Granted Patents)

Company Filing History:

20 out of 950

Gilead Sciences, Inc.

Gilead Pharmasset LLC

patents

5. 1 out of 5,538

Leland Stanford Junior University

patents

where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

PRMT5 Inhibitors

Peptidylarginine Deiminases

Hepatitis C Virus

Flaviviridae Viruses

Macrocyclic Inhibitors

Syk Inhibitors

Antiviral Compound Synthesis

Substituted Pyrrolidines

Prostratin Analogs

Bryostatin Analogs

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12448388 - PRMT5 inhibitors and uses thereof (2025-10-21),

2. 12240862 - Inhibitors of peptidylarginine deiminases (2025-03-04),

3. 11976083 - Inhibitors of peptidylarginine deiminases (2024-05-07),

4. 11878965 - Inhibitors of peptidylarginine deiminases (2024-01-23),

5. 10603318 - Inhibitors of hepatitis C virus (2020-03-31),

6. 10472392 - Macrocyclic inhibitors of flaviviridae viruses (2019-11-12),

7. 10335409 - Inhibitors of hepatitis C virus (2019-07-02),

8. RE47334 - Macrocyclic inhibitors of flaviviridae viruses (2019-04-01),

9. 10246486 - Macrocyclic inhibitors of flaviviridae viruses (2019-04-02),

10. 10030033 - Synthesis of an antiviral compound (2018-07-24),

11. 10005774 - Syk inhibitors (2018-06-26),

12. 9873716 - Macrocyclic inhibitors of flaviviridae viruses (2018-01-23),

13. 9655944 - Inhibitors of hepatitis C virus (2017-05-23),

14. 9642889 - [object Object] (2017-05-09),

15. 9617310 - Inhibitors of hepatitis C virus (2017-04-11),

Title: The Innovative Journey of Adam James Schrier

Introduction: Adam James Schrier is a renowned inventor based in Redwood City, CA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Adam James Schrier holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Adam James Schrier has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Adam James Schrier has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Adam James Schrier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.